Applied Genetic Technologies (AGTC) Priced

Biotech developing gene therapies for orphan eye diseases.

Health Care - Biotechnology

IPO Performance
Latest Trade $7.95 -0.15 (-1.9%)
First Day Return 23.0%
Return from IPO -32.5%
 
Applied Genetic Technologies IPO News more
  • .
IPO Data
IPO File Date 01/10/2014
Offer Price $12.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.2
Deal Size ($mm) 50
 
IPO Data
IPO Date 03/26/2014
Offer Price $12.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.2
Deal Size ($mm) $50
 
Underwriters
more
Business Overview
Biotech developing gene therapies for orphan eye diseases.
Biotech developing gene therapies for orphan eye diseases.
more
Company Data
Headquarters Alachua, FL
Founded 1999
Employees 17
Website www.agtc.com
 

Performance vs. IPO Index (IPOUSA)